173 related articles for article (PubMed ID: 4115562)
1. Immunoglobulin levels in polycythemia vera, erythrocytosis, secondary polycythemia and myelofibrosis.
Meytes D; Shacked N; Padeh B; Czerniak P; Pinkhas J; Ramot B
Isr J Med Sci; 1972 Jul; 8(7):925-31. PubMed ID: 4115562
[No Abstract] [Full Text] [Related]
2. Quantitative analysis of IGG, IGA and IGM immunoglobulins acute and chronic granulocytic leukemia, polycythemia vera and osteomyelosclerosis syndrome.
Kraj M; Ciesluk S
Arch Immunol Ther Exp (Warsz); 1971; 19(6):767-74. PubMed ID: 5004015
[No Abstract] [Full Text] [Related]
3. [Immunitary disorders during myeloid splenomegaly with myelofibrosis].
Boivin P; Hakim J; Kahn A; Bernard JF
Nouv Presse Med; 1972 Apr; 1(14):960. PubMed ID: 5019303
[No Abstract] [Full Text] [Related]
4. Plasma cytokines in polycythemia vera: phenotypic correlates, prognostic relevance, and comparison with myelofibrosis.
Vaidya R; Gangat N; Jimma T; Finke CM; Lasho TL; Pardanani A; Tefferi A
Am J Hematol; 2012 Nov; 87(11):1003-5. PubMed ID: 22965887
[TBL] [Abstract][Full Text] [Related]
5. Quantitative and functional studies of impaired natural killer (NK) cells in patients with myelofibrosis, essential thrombocythemia, and polycythemia vera. I. A potential role for platelet-derived growth factor in defective NK cytotoxicity.
Gersuk GM; Carmel R; Pattamakom S; Challita PM; Rabinowitz AP; Pattengale PK
Nat Immun; 1993; 12(3):136-51. PubMed ID: 8329837
[TBL] [Abstract][Full Text] [Related]
6. [Serum immunological abnormalities in myeloid splenomegaly and myelosclerosis].
Boivin P
Rev Roum Med Intern; 1973; 10(3):170-7. PubMed ID: 4123073
[No Abstract] [Full Text] [Related]
7. Serum immunoglobulin levels in humans exposed to therapeutic total-body gamma irradiation.
Chaskes S; Kingdon GC; Balish E
Radiat Res; 1975 Apr; 62(1):144-145. PubMed ID: 1054519
[No Abstract] [Full Text] [Related]
8. [Cytometric characteristics of erythrocytes in polycythemia vera].
Kotsiubinskiĭ NN; Dygin VP; Koval' IuV
Probl Gematol Pereliv Krovi; 1982 Mar; 27(3):33-6. PubMed ID: 7045861
[No Abstract] [Full Text] [Related]
9. [Quantity and rate of erythrocyte sedimentation in polycythemia vera and symptomatic erythrocytosis].
Shulaeva EV; Shupik EI; Gritsenko LA
Vrach Delo; 1978 Dec; (12):54-6. PubMed ID: 741725
[No Abstract] [Full Text] [Related]
10. Endogenous erythroid colony formation by peripheral blood mononuclear cells from patients with myelofibrosis and polycythemia vera.
Lutton JD; Levere RD
Acta Haematol; 1979; 62(2):94-9. PubMed ID: 119408
[TBL] [Abstract][Full Text] [Related]
11. [Alkaline phosphatase activity of the granulocytes in polycythemia vera and myelofibrosis].
Mariańska B; Leszko B; Maj S; Apel D
Acta Haematol Pol; 1987; 18(1-2):23-7. PubMed ID: 3434154
[No Abstract] [Full Text] [Related]
12. Evaluation of serum VEGF levels in untreated erythrocytosis patients.
Maktouf C; Bounemra A; Mahjoub S; Msadek F; Khlif A; Karoui M; Hdiji S; Zriba S; Romdhane NB; Elloumi M
Pathol Biol (Paris); 2011 Aug; 59(4):240-2. PubMed ID: 20674193
[TBL] [Abstract][Full Text] [Related]
13. Discrepancies of applying primary myelofibrosis prognostic scores for patients with post polycythemia vera/essential thrombocytosis myelofibrosis.
Gowin K; Coakley M; Kosiorek H; Mesa R
Haematologica; 2016 Oct; 101(10):e405-e406. PubMed ID: 27354022
[No Abstract] [Full Text] [Related]
14. [Quantitative immunoglobulin determination in leukemia and myelofibrosis].
Horváth T; Patakfalvi A; Böhm G; Kajtsa E
Haematologia (Budap); 1970; 4(3):319-26. PubMed ID: 5001991
[No Abstract] [Full Text] [Related]
15. [Glycosaminoglycans of human thrombocytes in normal conditions, in chronic myeloid leukosis, myelofibrosis and polycythemia vera].
Kharchenko MF
Vopr Med Khim; 1973; 19(6):613-7. PubMed ID: 4277844
[No Abstract] [Full Text] [Related]
16. Leukemia-associated antigens in leukemic transformation of polycythemia vera.
Pisciotta AV; Cronkite C; Hanson GA; Brodsky JB; Donovan PB; Wasserman LR
J Lab Clin Med; 1983 Mar; 101(3):432-40. PubMed ID: 6827175
[TBL] [Abstract][Full Text] [Related]
17. [Hypocholesterolemia and other lipoprotein disorders in myelofibrosis].
Kiss A; Telek B; Rák K
Orv Hetil; 1994 Nov; 135(48):2643-6. PubMed ID: 7808738
[TBL] [Abstract][Full Text] [Related]
18. Investigations of the role of immunological mechanisms in spinal muscular atrophy.
Jezierska K
Pol Med J; 1972; 11(5):1319-25. PubMed ID: 4119323
[No Abstract] [Full Text] [Related]
19. [Characteristics of the morphology and function of the thrombocytes in myeloproliferative diseases].
Petrov MN; Vashkinel' VK
Probl Gematol Pereliv Krovi; 1977 May; 22(5):18-23. PubMed ID: 267283
[No Abstract] [Full Text] [Related]
20. Intracellular growth factors in polycythemia vera and other myeloproliferative disorders.
Eid J; Ebert RF; Gesell MS; Spivak JL
Proc Natl Acad Sci U S A; 1987 Jan; 84(2):532-6. PubMed ID: 3467372
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
